Nasdaq:US$19.94 (-0.15) | HKEX:HK$31.40 (-0.65) | AIM:£3.15 (-0.09)
Major Shareholders

HUTCHMED has issued a total of 871,264,820 ordinary shares. Each Nasdaq-listed American Depositary Share (ADS) equates to five ordinary shares.

For illustrative purposes only, if converted in their entirety, this would be equivalent to 174,252,964 Nasdaq-traded ADSs.

Insofar as HUTCHMED is aware, approximately 39.89% of the issued share capital of HUTCHMED is not in public hands. Such percentage comprises the shares held by Directors, Executive Officers, and CK Hutchison Holdings Limited, a significant shareholder of HUTCHMED.

The disclosure of certain major and significant shareholdings in the share capital of HUTCHMED is governed by (i) the provisions of rule 5 of the Disclosure Guidance and Transparency Rules of the U.K. Financial Conduct Authority (DTR) (which have been incorporated by reference into the Company's Articles of Association); (ii) the US Securities Exchange Act of 1934; and (iii) the Hong Kong Securities and Futures Ordinance (Cap. 571).

Insofar as HUTCHMED is aware, the interests of its shareholders holding 3% or more of the issued share capital of HUTCHMED and its directors are set out in the tables below.

Last updated: May 2, 2024

Significant Shareholders

Name Total Number of Shares Held / Interested Approx. % of Total Issued Shares
CK Hutchison Holdings Limited ("CKHH") (1) 332,574,650 38.18%
M&G Plc (2) 43,173,457 4.96%
CA Fern Parent (3) 40,847,500 4.69%
Notes:
The above table sets out the interests of certain shareholders, insofar as HUTCHMED is aware based on public disclosure as of June 30, 2023. Includes the interests and short positions in the shares or underlying shares of the Company which would fall to be disclosed to the Company under the provisions of Divisions 2 and 3 of Part XV of the SFO, or which were recorded in the register required to be kept by the Company under Section 336 of the SFO, or as otherwise notified to the Company and HKEX under Part XV of the SFO. For details of the capacity of each substantial shareholder’s interests, please refer to the “Interests and Short Positions of Shareholders Discloseable under the Securities and Futures Ordinance” section in the 2023 Interim Report. The above table includes Long Positions only – excludes short positions and lending pools. (1) Please refer to 2023 Interim Report for details. As of July 15, 2021, notified via disclosure form 2 filed with the Hong Kong Stock Exchange on July 19, 2021. (2) As of November 2, 2023, notified via disclosure form 2 filed with the Hong Kong Stock Exchange on November 3, 2023.  An aggregated 44,433,217 ordinary shares (long position) are held by M&G Plc indirectly through its certain subsidiaries.
(3) CA Fern Parent is wholly owned by several entities which are, by and through their control affiliates (including their respective general partners), ultimately controlled (directly or indirectly) by The Carlyle Group Inc., but The Carlyle Group Inc. has no beneficial interest in the underlying securities of the Company. As of June 30, 2021, notified via disclosure form TR-1 filed on AIM on July 2, 2021.

Directors

Name Total Number of Shares/Underlying Shares Held Approx. % of Total Issued Shares
Weiguo SU 8,162,525 0.94%
Johnny CHENG 2,695,625 0.31%
Edith SHIH 1,200,000 0.14%
Dan ELDAR 150,660 0.02%
Tony MOK 136,705 0.02%
Paul CARTER 108,925 0.01%
Graeme JACK 86,695 0.01%
Renu Bhatia 16,000 0.002%
Ling YANG 0 0%
Total 12,557,135
Notes: As of May 20, 2024. Includes the interests and short positions of the Directors and chief executive of the Company in the shares, underlying shares and debentures of the Company or any of its associated corporations (within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the “SFO”)) which were notified to the Company and The Stock Exchange of Hong Kong Limited (the “HKEX”) pursuant to Divisions 7 and 8 of Part XV of the SFO (including interests and short positions which the Directors and chief executive of the Company were deemed or taken to have under such provisions of the SFO), or which were recorded in the register required to be kept by the Company pursuant to Section 352 of the SFO, or as otherwise notified to the Company and the HKEX pursuant to the Code on Dealings in Shares by Directors adopted by the Company. For details of the capacity and nature of each Director’s interests, please refer to the “Disclosure of Interest” section in the 2023 Interim Report.